A bioassay for HIV-1 based on Env-CD4 interaction
- PMID: 2078409
- DOI: 10.1089/aid.1990.6.1281
A bioassay for HIV-1 based on Env-CD4 interaction
Abstract
The binding of human immunodeficiency virus type 1 (HIV-1) gp120env to CD4 is the first event leading to infection and represents an important target for possible therapeutic intervention. To provide a tool for screening and quantitation of the effects of drugs inhibiting the Env-CD4 interaction, we developed a simple, fast and quantitative bioassay measuring the fusion between two cell lines generated by stable transfection: one expressing high levels of HIV-1 proteins but no infectious virus (HL2/3), and the other expressing the CD4 receptor and containing an inducible chloramphenicol acetyltransferase (CAT) gene linked to the HIV-1 long terminal repeat (HLCD4-CAT). Upon cocultivation of HL2/3 and HLCD4-CAT cells, efficient cell fusion is observed within 8 h. The efficiency of fusion can be evaluated visually and quantitated by measuring CAT enzyme. This novel bioassay allows testing for drugs capable of interfering with the CD4-Env interaction. HL2/3 cell line secretes gp120env in the medium and can be used for the production of Env protein.
Similar articles
-
An anti-human immunodeficiency virus multiple antigen peptide encompassing the cleavage region of the env precursor interferes with membrane fusion at a post-CD4 binding step.Virology. 2000 Jul 20;273(1):169-77. doi: 10.1006/viro.2000.0368. Virology. 2000. PMID: 10891419
-
Interactions of CCR5 and CXCR4 with CD4 and gp120 in human blood monocyte-derived dendritic cells.Exp Mol Pathol. 2000 Jun;68(3):133-8. doi: 10.1006/exmp.1999.2300. Exp Mol Pathol. 2000. PMID: 10816381
-
Productive infection and subsequent interaction of CD4-gp120 at the cellular membrane is required for HIV-induced apoptosis of CD4+ T cells.J Gen Virol. 1995 Mar;76 ( Pt 3):681-90. doi: 10.1099/0022-1317-76-3-681. J Gen Virol. 1995. PMID: 7897356
-
Evaluation of the cytopathicity (fusion/hemifusion) of patient-derived HIV-1 envelope glycoproteins comparing two effector cell lines.J Biomol Screen. 2012 Jul;17(6):727-37. doi: 10.1177/1087057112439890. Epub 2012 Mar 16. J Biomol Screen. 2012. PMID: 22427259
-
The role of CD4 in HIV binding and entry.Philos Trans R Soc Lond B Biol Sci. 1993 Oct 29;342(1299):59-66. doi: 10.1098/rstb.1993.0136. Philos Trans R Soc Lond B Biol Sci. 1993. PMID: 7904348 Review.
Cited by
-
NMR-assisted computational studies of peptidomimetic inhibitors bound in the hydrophobic pocket of HIV-1 glycoprotein 41.J Comput Aided Mol Des. 2013 Jul;27(7):569-82. doi: 10.1007/s10822-013-9662-6. Epub 2013 Jul 27. J Comput Aided Mol Des. 2013. PMID: 23893342 Free PMC article.
-
Membrane-anchored HIV-1 N-heptad repeat peptides are highly potent cell fusion inhibitors via an altered mode of action.PLoS Pathog. 2009 Jul;5(7):e1000509. doi: 10.1371/journal.ppat.1000509. Epub 2009 Jul 10. PLoS Pathog. 2009. PMID: 19593361 Free PMC article.
-
Surfactant protein D inhibits HIV-1 infection of target cells via interference with gp120-CD4 interaction and modulates pro-inflammatory cytokine production.PLoS One. 2014 Jul 18;9(7):e102395. doi: 10.1371/journal.pone.0102395. eCollection 2014. PLoS One. 2014. PMID: 25036364 Free PMC article.
-
T30177, an oligonucleotide stabilized by an intramolecular guanosine octet, is a potent inhibitor of laboratory strains and clinical isolates of human immunodeficiency virus type 1.Antimicrob Agents Chemother. 1995 Nov;39(11):2426-35. doi: 10.1128/AAC.39.11.2426. Antimicrob Agents Chemother. 1995. PMID: 8585721 Free PMC article.
-
Potent strategy to inhibit HIV-1 by binding both gp120 and gp41.Antimicrob Agents Chemother. 2011 Jan;55(1):264-75. doi: 10.1128/AAC.00376-10. Epub 2010 Oct 18. Antimicrob Agents Chemother. 2011. PMID: 20956603 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous
